0001415889-19-001255.txt : 20191104
0001415889-19-001255.hdr.sgml : 20191104
20191104160519
ACCESSION NUMBER: 0001415889-19-001255
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191031
FILED AS OF DATE: 20191104
DATE AS OF CHANGE: 20191104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AHMED NADIM
CENTRAL INDEX KEY: 0001731193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 191189761
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
form4-11042019_041106.xml
X0306
4
2019-10-31
0000816284
CELGENE CORP /DE/
CELG
0001731193
AHMED NADIM
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
false
true
false
false
PRES., GLOBAL HEM. AND ONC.
Common Stock
2019-10-31
4
M
0
3281
0
A
15915
D
Common Stock
2019-10-31
4
F
0
1096
108.03
D
14819
D
Common Stock
1966
I
401(k) Plan
Restricted Stock Unit
2019-10-31
4
M
0
3281
0
D
Common Stock
3281
0
D
The restricted stock units granted to the reporting person on October 31, 2016 have vested and settled for shares of the Company's common stock.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan).
/s/ Jonathan Biller, Attorney-in-Fact
2019-11-04